Voya Investment Management LLC Raises Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Voya Investment Management LLC boosted its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 4.7% during the fourth quarter, HoldingsChannel reports. The firm owned 212,342 shares of the company’s stock after buying an additional 9,539 shares during the period. Voya Investment Management LLC’s holdings in Privia Health Group were worth $4,151,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Privia Health Group by 15.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 73,416 shares of the company’s stock worth $1,436,000 after acquiring an additional 9,880 shares during the last quarter. BlackBarn Capital Partners LP boosted its holdings in shares of Privia Health Group by 65.8% in the 4th quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company’s stock worth $12,969,000 after purchasing an additional 263,397 shares in the last quarter. State of Tennessee Department of Treasury increased its position in shares of Privia Health Group by 18.1% during the 4th quarter. State of Tennessee Department of Treasury now owns 57,075 shares of the company’s stock valued at $1,116,000 after purchasing an additional 8,733 shares during the last quarter. MetLife Investment Management LLC raised its holdings in shares of Privia Health Group by 5.8% during the 4th quarter. MetLife Investment Management LLC now owns 62,336 shares of the company’s stock valued at $1,219,000 after buying an additional 3,406 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Privia Health Group by 10.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company’s stock worth $27,687,000 after buying an additional 138,747 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Barclays lifted their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 10th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research note on Thursday, April 10th. JMP Securities restated a “market outperform” rating and set a $29.00 price target on shares of Privia Health Group in a research report on Monday. Robert W. Baird lifted their price objective on Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a report on Tuesday, April 15th. Finally, Truist Financial raised their price target on Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and an average target price of $27.38.

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now directly owns 179,676 shares of the company’s stock, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 10.70% of the company’s stock.

Privia Health Group Stock Down 2.5 %

Shares of NASDAQ PRVA opened at $22.90 on Friday. The company has a 50 day moving average of $23.52 and a 200 day moving average of $22.03. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The firm has a market cap of $2.78 billion, a P/E ratio of 229.02, a PEG ratio of 3.47 and a beta of 0.88.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.